U.S. market Open. Closes in 5 hours 35 minutes

SCPS | Scopus BioPharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses11.71M27.63M10.16M2.69M685.96K
Selling, General & Admin9.03M12.61M2.73M2.23M408.43K
Research & Development2.68M15.02M7.42M463.11K277.54K
Other Operating ExpensesN/AN/AN/AN/AN/A
Operating Income-11.71M-27.63M-10.16M-2.69M-685.96K
Other Expenses / Income105.05M681.21K-706.45KN/A-685.96K
Before Tax Income-11.71M-26.95M-10.86M-2.69M-685.96K
Income Tax Expenses-105.05K774.68K706.45K1.00-847.11K
Net Income-11.61M-27.73M-11.57M-2.69M-685.96K
Interest ExpensesN/A774.68K706.45KN/AN/A
Basic Shares Outstanding21.09M17.25M13.36M14.98M14.98M
Diluted Shares Outstanding21.09M17.25M13.36M14.98M14.98M
EBITDA-11.71M-27.63M-10.15M-2.69M-685.96K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-11.71M-26.18M-10.16M-2.69M-1.53M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙